There is a substantial need for new approaches to treating childhood cancers. TARGET aims to help advance the identification and preclinical validation of therapeutic targets for childhood cancers, which could ultimately lead to the development of innovative new therapies for pediatric cancer patients.
The cancers initially selected for study by the TARGET Initiative are acute lymphoblastic leukemia (ALL) and neuroblastoma. ALL is one of the most commonly diagnosed types of leukemia in children while neuroblastoma is the most common extracranial (outside of the brain) solid tumor in children and is most often diagnosed during the first five years of life.
Read more about the cancers selected for study in TARGET, other childhood cancers, and the additional resources available:
Areas of Research
Learn more about the three areas of research for TARGET and the importance of each.
Cancers Selected for Study
Learn more about the types of pediatric cancers being studied.